Patient-Friendly Explanation
Tirzepatide (brand names Mounjaro and Zepbound) is a once-weekly injection that helps with weight loss by reducing appetite and slowing stomach emptying. It works on two natural hormone pathways instead of one, making it one of the most effective weight loss medications available today.
Clinical Definition
Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist administered as a once-weekly subcutaneous injection. It enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and reduces appetite via central nervous system effects. Clinical trials (SURMOUNT-1) demonstrated mean weight loss of up to 22.5% at 72 weeks with the 15mg dose.